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HgCI2 induces an autoimmune disease in the
Brown Norway rat characterized by synthesis of
autoantibodies (mainly, anti-GBM Abs), severe
proteinuria and interstitial nephritis. Also, HgCI2-
injected rats develop glomerular cell infiltrates
consisting of ED1 cells (monocyte/macrophage),
starting on day 4 and reaching a maximum on
day 8. Treatment with anti-TNF- antiserum had
preventative effects as it reduced the urinary
protein levels to close to the normal range and
also blocked the influx of inflammatory cells in
the renal glomeruli and interstitium, but circulat-
ing anti-GBM and lineal glomerular IgG deposits
were unmodified. In addition, whole isolated glo-
meruli from HgCl2-induced nephritis secreted
TNF- commencing on day 8, being maximally
detected on day 11 and preceding, between 2 to 3
days, the development of proteinuria. The admin-
istration of anti-TNF-u antiserum or anti-4
integrin mAb completely abrogated the synthesis
ofTNF- in glomeruli isolated from the respective
treated groups of animals, in addition to the pro-
teinuria. Taken together our results confirm that
TNF- plays an important role in the induction
and development of HgCl2-induced nephritis and
highlights the pathogenic importance of the local
release of TNF in those renal diseases in which
prominent glomerular macrophage accumulation
is a constant feature.
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Introduction
Mercuric chloride (HgCl2) induces an auto-
immune disease in the Brown Norway (BN) rat
mediated by T-dependent polyclonal B-cell acti-
vation
2 resulting in hypergammaglobulinaemia,
synthesis of anti-nuclear and anti-glomerular
basement membrane (GBM) autoantibodies as
well as development of nephritis with glomerular
1-3 lineal deposits of Ig and proteinuria.- The h’s-
tological renal lesions consist of a transient influx
of mononuclear cells (mainly MHC class II-
beating T-lymphocytes and monocytes) into the
renal interstitium and monocytes and CD8 + T
lymphocytes into the glomeruli.
4
It has been shown recently that interaction
between lymphocytes and endothelial cells (EC)
is crucial in the development of this renal
disease.5 Treatment with Abs against the cz4-
integrin abrogated the development of interstitial
nephritis and virtually abolished the anti-GBM
Abs production. Consequently, glomerular
deposition of anti-GBM Abs was absent and pro-
teinuria was reduced to levels close to the
normal range. In contrast, anti-DNA Abs synthesis
was unaffected by this treatment, suggesting a
selective immunosuppressive role in the anti-z4-
integrin Ab.
The role of lymphokines in leukocyte recruit-
ment to inflammatory sites has been well docu-
mented. The increased expression of counter-
receptors for leukocyte adhesion proteins, such
as intercellular cell adhesion molecule (ICAM-1),
endothelial cell adhesion molecule (ELAM-1) and
vascular cell adhesion molecule (VCAM-1) on EC,
has been identified in sites of inflammation,
67 including target organs for autoimmunity.
Cytokines (especially TNF-, IL-1 and IFN-3,)
activate endothelial cells to synthesize and to
increase the expression of adhesion molecules
and conversely, engagement of these molecules
on the surface of such cells can induce and/or
mediate cytokine expression.7’8 Recently, treat-
ment of autoimmune diseases with cytokine ago-
nists and their antagonists has been attempted in
order to establish their clinical usefulness in the
prevention of these disorders. Inflammatory med-
iators, such as TNF-cz and IL-13, have been
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extensively investigated in autoimmune diseases Experimental procedure: Three groups of rats
and their potential pro-inflammatory effects were injected s.c., three times a week, over a
demonstrated by increasing the severity of the period of 2 weeks with 100 },tg of HgCI2 per
glomerular injury in both rats and rabbits in the 100 g/body vv’t.
28 Animals from Group I (n 20)
anti-GBM antibody mediated model of nephri- did not receive any additional treatment. Rats
tis.9’1 In addition, in the renal cortices of lupus belonging to Group II (n 20) received an i.p.
nephritic mice an enhancement of mRNA for injection (25000 IU) of anti-TNF-a on days 0, 8
TNF-a and IL-113 has been observed.
1 Also, an and 13 and those from Group III (n 20)
augmented production of TNF has been demon- received an i.p. injection (0.5 mg) of HP2/1 mAb
strated in the nephritic glomeruli in anti-GBM on days 0, 8 and 13. A fourth group (Group IV)
glomerulonephritis (GN).
12 Moreover, it has (n 20) served as a normal control in which
been shown that the administration of anti-TNF rats were injected only with H20 adjusted to the
antiserum abrogated the development of nephro- same pH (3.8) as the HgCl2 solution, following
13 15 th r toxic nephritis in the rat. Taken toge e, the same procedure described above for the
these data suggest that TNF-a and IL-113 can be mercury administration. The dosages and days
regarded as potential mediators of glomerular were established on the basis of previous opti-
injury, playing an important role in the induction mizing experiments and our appreciation of the
and development of renal autoimmune diseases, kinetics of the disease.5 All animals were sequen-
The presence of both TNF-a and VI-a4-integ- tially bled on different days of the experiment by
rin has proved to be necessary for the develop- tail artery puncture. Four rats from each group
ment of proteinuria and accumulation of were killed on days 4, 8, 11, 13 and 23 and
inflammatory cells in other rat models of nephri- kidneys were processed for study.
tis,
5 unlike the requirements found in other
models of renal diseases where complement and Proteinuria: Rats were maintained in metabolic
neutrophil-induced vascular injury are induced by cages for 24h with free access to food and
deposition of immune complexes. water. Urine samples were taken at regular inter-
Using the experimental model of autoimmune vals starting on day 0. Proteinuria was measured
renal disease described in this paper, we have by using a Bio-Rad assay (Bio-Rad, Richmond,
examined in depth the required presence of CA), according to the manufacturer’s protocol.
TNF-a for circulating leukocyte accumulation (in Urine samples were assayed in triplicate. The OD
both glomerular and renal interstitium)as well as from each sample was measured in a Titertek
in the development of proteinuria. Multiskan Plus (Flow, Irvine, UK) at 595 nm.
Anti-GBM and anti-ssDNA Abs assay.. Rat GBM
M,ri nd,hd was isolated, essentially, as described by Bowman
et a/.29 Briefly, glomeruli were obtained from
Animals: Brown Norway rats, weighing 180 to normal BN rats by differential sieving and cen-
200g, were obtained from IFFA-CREDO (Paris, trifugation of minced kidney cortices. The glo-
France) and from our own breeding colony, and merular suspension was sonicated, washed and
maintained under standard conditions, lyophilized. The GBM was digested with Type I
collagenase (Sigma Chemical Co., St Louis, MO)
Antibodies: Rabbit anti-human TNF- polyclonal at 0.7% w/w for I h at 37C. Anti-GBM Abs were
antibody, which binds to human TNF- and rat measured by ELISA as described previously.
2
TNF-a,
17 was obtained from Genzyme Co. (Cam- Anti-ssDNA Abs were measured by an ELISA
bridge, MA). The mouse anti-human HP2/1 mAb developed in our laboratory.
5 All the samples
recognizes the VLA-a4-integrin
8 and cross-reacts were assayed in quadruplicate.
with the rat VI-4.9 This mAb blocks the inter- Samples of a serum pool from untreated BN
action of both a4131 and t47 integrins with its rats and from BN rats which were treated with
20 21 two known ligands, FN and VCAM-1. The fol- HgCl2 and bled on day 13 of the disease served
lowing antibodies were purchased from Serotec as negative and positive controls, respectively.
(Oxford, UK): OX19, which recognizes the CD5 Results were expressed as the percentage of
antigen;22’23 W3/25, which reacts with a subset of binding obtained with samples from positive
peripheral T cells expressing the CD4 antigen;
24 control serum.
OX8, which recognizes a stable determinant of
the rat CD8 heterodimer;
25 OX6 mAb, which Isolation and culture of glomeruli: Harvested
recognizes the rat MHC class II antigens (RT1- kidneys from the four experimental groups of
B);iand ED1 mAb, which reacts with rat mono- rats were decapsulated and the renal medulla
cytes and macrophages.
2r removed. The dissected cortex was then minced
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with a razor blade in Hanks’ balanced salt solu-
tion (HBSS) and seived through decreasing pore
size (250, 150 and 751.tm) as described pre-
viously. Glomeruli were finally collected on the
top of a 75 I.tm sieve, with the suspension con-
taining more than 95% of glomeruli free of
tubular fragments. Preparations were suspended
at a final concentration of 5 000 glomeruli/ml in
RPMI 1640 (Whittaker Bioproducts, Walkerville,
MD) containing 10% (v/v) FCS (Flow), ampicillin
(100 l.tg/ml) and streptomycin (100 l.tg/ml), and
then incubated in 24-well plates (Nunc, Roskilde,
Denmark) (5000 glomeruli/well) at 37C in a 5%
CO2 atmosphere. Supernatants were harvested at
24h, centrifuged at 100g and stored at -20C
until assayed for the release of TNF.
All samples were screened for the presence of
endotoxin by using the Limulus amoebocyte
lysate (L.A.L.) assay (Whittaker). Briefly, dilutions
were performed from standard endotoxin (0.5 to
0.03 E.U./ml, 1 E.U. 0.1 ng/ml of endotoxin) as
positive control as well as for our samples (using
serial dilutions, 1:2 to 1:64). Non-pyrogenic water
was used as negative control. All samples were
assayed in quadruplicate. One hundred l.tl of
L.A.L. (sensibility, 0.1 E.U./ml) was added to each
sample and then were incubated at 37C for i h.
The endotoxin concentration was obtained as
the product of the lysate sensibility per the ’limit
point dilution’ (the last dilution showing reaction
with the L.A.L.). The limit of detection in the
assay was 10 pg/ml, with all the samples screened
showing less than 10pg/ml.
TNF<, assay: The TNF-a activity was determined
by standard MTT method on L929 cells (ATCC,
Rockville, MD) in the presence of actinomycin
D (ll.tg/ml). Briefly, 3 x 10
4 cells/well were
resuspended in DMEM (Whittaker) containing
10% (v/v) FCS, ampicillin (100 l.tg/ml), strepto-
mycin (100 l.tg/ml), and glutamine (10mM) and
further incubated overnight on fiat-bottomed, 96-
well plates (Nunc) at 37C. Dilutions of super-
natants from cultured glomeruli were added in
triplicate. Also, half-los dilution ,of hrTNF (spe-
cific activity, 2 x 10 to 2 109 units/ml)
(Genzyme) ranging from 200t.tg/ml to i pg/ml
was added to some wells to produce a standard
curve. A 251.tl aliquot of MTT stock solution
(5 mg/ml) was added to each of the wells and
incubated for 4 h at 37C. The supernatants were
removed by careful aspiration and 200 I.tl of a 1:1
DMSO and ethanol mixture to solubilize the
crystals was then added to each well. The plates
were shaken gently and OD (to 595nm) was
determined using a Titertek Multiskan Plus.
For neutralization studies, anti-TNF-a Ab or
control sera were added simultaneously to wells
containing 400pg/ml of hrTNF-a (producing
50% lysis of 3 x 104 L929 cells, in our experi-
ments) or test samples, with a final concentration
of 50% (v/v). This Ab neutralizes 2000U of
rTNF-a.31 No TNF-a activity was found on L929
cells in those wells incubated with anti-TNF-a
Abs.
Concentrations of TNF-a were extrapolated
from a standard curve with known hrTNF-a dilu-
tions. Results are expressed as pg/ml of TNF.
Kidney tissue processing: On days 13 and 23, rat
kidneys (n 4) from the groups I, II and IV
were processed for histological and immunohis-
tochemistry studies. For light microscopy, 3 l.tm
paraffin-embedded kidney sections were stained
with periodic acid-Schiffs (PAS). For immunohis-
tochemistry studies, pieces of renal tissue were
snap-frozen in isopentane precooled in liquid
nitrogen, and stored at -70C until used. Direct
immunofluorescence studies were performed on
ether/ethanol-fixed serial cryostat sections, by
using FITC-conjugated rabbit anti-rat IgG
(Serotec), as described previously.
2 In addition,
the glomerular cell infiltrates were characterized
in the kidneys of rats (n 4) injected with
mercury and in two control animals on days 4, 8,
13 and 23. These tissue kidneys were stained
with an indirect immunophosphatase method
(APAAP) using a panel of mAbs. The specificity
of these mAbs was assessed by using normal
serum, normal mouse IgG, and hybridoma-
induced ascitic fluids containing unrelated Abs.
Positive controls of the reagents were sections of
normal rat spleen. These studies were performed
by using a conventional light microscopy objec-
tive ( x 63), as described previously.34
Statistical analysis: The results are given as mean ___
S.D. Values obtained from the levels of protei-
nuria and ELISA results were analysed using the
Student’s t-test. For TNF assay, statistical analysis
was performed by using a Wilcoxon rank-sum
method for non-parametric significance testing.
Results
Effect of anti-TNF<, treatment on the protei-
nuria: As shown in Fig. 1, rats belonging to the
Group I developed proteinuria in two different
phases. A first short phase, which occurred
immediately after the first injection of HgCl2, due
to the direct effect of mercury on tubular renal
cells. This first phase was followed by a second
phase starting on day 11 and declining after day
16 of the disease. On day 23, all the animals
reached the background levels. When the rats
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FIG. 1. Time course of urine protein excretion in, normal control
rats (Group IV) (,) compared with HgCI2-injected rats (Group I)
(,) and anti-TNF--treated rats (Group II) (0). The results are
expressed as mean ___
S.D. Statistical analysis was performed by
Student’s t-test comparing Group and I1. /values were
<0.001.
were treated with anti-TNF-a Ab (Group II), a
drastic reduction (about 90%, p < 0.001) in the
urinary protein levels were found as compared
with Group I (20.21 +_ 7.99 mg/24 h vs.
128.04 +_ 30.25 mg/24 h). The same effect was
observed when rats were treated with anti-a4
integrin Abs (HP2/1 mAb).5 In both situations,
the first phase of proteinuria was unaffected.
Effect of anti-TNF<x treatment on anti-GBM and
anti-ssDNA synthesis.. Increased anti-GBM Ab
concentration in the serum from rats injected
with merculT (Group I, Fig. 2A) was detected by
ELISA from day 8, with the mammal concentra-
tion being observed on day 13 of the disease.
After day 13, serum levels of anti-GBM Abs
started to decline as also occurred with the pro-
teinuria. The serum levels of anti-ssDNA Abs in
this same Group I (Fig. 2B) showed a significant
increase, first observed on day 4, but their kinet-
ics of secretion were different from the anti-GBM
Abs production.
In contrast to that found in BN rats treated
with HP2/1 mAbs, which showed a significant
(p<0.001) reduction in the anti-GBM Abs
serum levels,
5 the group of rats treated with anti-
TNF-z Abs (Group II) presented circulating anti-
GBM Abs levels similar to those found in Group
I (HgCl2-injected rats) (Fig. 2A). All the groups
analysed, with the exception of the negative
control group (Group IV), showed the same
kinetics as found in the anti-ssDNA Abs synthesis
175
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RG. 2. Levels of circulatin9 autoantibodios. Titre of serum anti-GBM Abs (A) and anti-ssDNA Abs (B) durin9 the experiment in normal
rats (Group IV) (&) compared with HgCI2-injoctod rats (Group I) () and anti-TF-treatod rats (Group II) (). The values are 9iron as
mean S.D.
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FIG. 3. Interstitial inflammatory cells accumulation in HgCI2-treated rats (Group I) (A) showing severe perivascular renal cell infiltrates.
Group of rats treated with anti-TNF- Abs (Group II) (B) shows the absence of inflammatory cells in the renal interstitium (PAS, x 20).
Both groups (I and II) (C, -IF x 500; and D, -IF x 425; respectively) show positive linear GBM deposits of rat IgG.
(Fig. 2B). None of the treatments affected the
ssDNA Abs production.
Histopathology and immunofluorescence studies
on kidneys: Renal tissues from rats treated with
I’gCl2 (Group I) and HgCl2 plus anti-TNF-a Abs
(Group II) (n 4 rats/group), were examined
by light microscopy on days 13 and 23 of the
disease (Fig. 3A and B). As reported pre-
viously,’5 kidney tissues from BN rats injected
with mercury presented a severe interstitial
mononuclear cell infiltrate. The inflammatory
cells were preferentially located in the perivas-
cular regions of the renal interstitium. However,
in the same group of rats treated with anti-TNF-a
Abs, cell infiltrates were not observed in the
renal interstitium (Fig. 3B). Kidneys from HiO-
injected rats showed a normal renal histology.
Phenotypic analysis of glomerular cell infil-
trates are given in Table 1. We found an impor-
Table 1. Glomerular leukocytes during HgCI2-induced nephritis
Number of positive cells/glomerulus*
mAb 0 4 8 13 23
OX6 0.40 _-/- 0.07:1: 0.65 ___
O. 15 1.56 ___
0.60* 1.53 ___
0.50*
ED1 0.30 ___
0.06 0.67 ___
0.03* 1.30 -t- 0.28* 0.50 ___
0.21
OX8 0.22 _
0.07 0.20 ___
0.05 O. 17 ___
0.06 0.70 ___
0.10"
0.33 ___
0.15
0.27 ___
O. 10
0.20 0.03
*Six rats, and two sections per rat were examined for each mAb. Twenty glomeruli were counted per section.
tResult are expressed as mean -t- S.D.
*p < 0.01.
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FIG. 4. TNF concentration from glomerular cultured super-
natants. A. Glomerular TNF- production (open bar) from HgCI2-
injected rats (Group I) and relationship between the develop-
ment of proteinuria (0). B and C show the results obtained from
glomerular cultured supernatants belonging to anti-TNF- treated
rats (Group II) and anti-4 integrin (HP2/1)-treatment rats (Group
III), respectively. Filled bar represents the TNF<z concentration
from glomerular cultured supernatants from control rats (Group
IV). Results shown represent the mean -I- S.D. *p < 0.01, and
**p < 0.05.
tant increase in the number of monocyte/macro-
phage (ED1 + cells) on day 4 (0.67 cells/glomer-
ulus) as compared with day 0 (0.30 cells/
glomerulus), with this increase being maximal on
day 8 (1.30 monocytes/glomerulus). Never-
theless, on day 13 of the disease, the number of
mono+cytes decreased, and CD8+ lymphocytes
(OX8 cells) had significantly increased in com-
parison with the number on day 0 (0.22 cells/
glomerulus and 0.70 cells/glomerulus, respec-
tively). Both monocytes (ED1 +) or CD8+ lym-
phocytes (OX8 +), in the glomerular cell
infiltrates, also bear the Ia+ antigen cell marker
(Table 1).
On the other hand, when rat kidney tissues
were examined by direct immunofluorescence
studies, rat IgG showed a positive linear pattern
deposition along the GBM in both HgCli-injected
and anti-TNF<z-treated rats (but not control rats),
at day 13 of the disease (Fig. 3C and D).
Kinetics of TNF<x secretion by culturing glomer-
uli: TNF-ez concentration from glomerular cul-
tured supernatants was measured after 24h
incubation by using a bioassay. As shown in
Fig. 4A, the TNF-z levels in supernatants from
cultured HgCla-injected rat (Group I) glomeruli
started to increase before day 8 of the disease,
reached a peak on day 11 (p < 0.01), and then it
declined by day 12. Figure 4A illustrates both the
kinetics of TNF-ez production and the urinary
protein excretion. Interestingly, TNF-0t produc-
tion preceded the development of proteinuria by
2-3 days. When TNF<z production was analysed
in glomeruli isolated from rats belonging to both
Groups II (anti-TNF<z treated) and III (anti<z4
treated), no significant levels of this cytokine was
detected (Fig. 4B and C), in accordance with the
low urinary protein levels.
Discussion
The autoimmune disease induced in the BN
rats by the injection of HgC12 is characterized by
the synthesis of autoantibodies (mainly, anti-GBM
Abs) due to a polyclonal B cell activation. The
renal lesions consist of rat Ig deposition on the
glomerular basement membrane with an influx
of mononuclear cells and the development of
proteinuria.
1-4 The administration of anti-TNF-ot
antiserum to HgCli-injected rats significantly
reduced the urinary protein levels but the synth-
esis of anti-GBM Abs as well as glomerular
deposits of Ig remained unaffected. In addition,
no infiltrating interstitial cells were found in this
group of rats. These findings suggest that TNF<z
plays an important role in the development of
this renal injury, as has been demonstrated pre-
viously in other different experimental models of
nephritis.14’5
The elevated serum production of auto-
antibodies observed after anti-TNF-a treatment
strongly suggests that this antiserum acts mainly
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at a local level. More evidence supporting this
local anti-TNF<, Abs effect was obtained when
we studied the production of TNF-a from iso-
lated nephritic glomeruli. The glomeruli from
HgC12-treated rats secreted TNF-a between days
4-8 to the day 11 of the disease. Also, the studies
carried out on the glomerular cell infiltrates in
HgCli-injected rats demonstrated an influx of
monocytes on day 4 of the disease with the
highest number of infiltrating glomerular cells
having been observed on day 8. On the other
hand, an increase in the number of CD8 + lym-
phocytes was seen in the nephritic glomeruli on
day 13. Moreover, the treatment with the anti-a4
integrin mAb to HgCli-injected rats completely
abrogated the secretion of TNF-0t from rat glo-
meruli. The 0t4 integrin, an adhesion molecule
expressed by almost all leukocytes, interacts with
VCAM-1 (an endothelial pro-inflammatory induci-
ble cell molecule), as well as with the alternative
spliced form (CS-1) of FN, playing a central role
in mediating leukocyte adhesion, extravasation,
and migration to sites of inflammation.5’36 As
has been previously demonstrated,
5 the adminis-
tration of anti-a4 integrin mAb to HgCli-injected
rats blocked the influx of circulating leukocytes
into the renal interstitium and the accumulation
of monocytes in the renal glomeruli. These data
might suggest that infiltrating glomerular mono-
cytes are the major source of glomerular TNF.
The results presented here are in agreement with
those previously reported by Tipping et al.
12
demonstrating the association between the glo-
merular monocyte infiltration and glomerular
injury in anti-GBM nephritis. Nevertheless, the
initial source of TNF in the glomerulus is still not
entirely understood. It is well documented that
resident glomerular cells can be responsible for
TNF secretion. The stimulation of mesangial cells
with LPS induces the synthesis of TNF-ot,7 and
the in vivo administration of LPS also induces
glomerular TNF-a mRNA expression in the
absence of leukocyte cells infiltration.8 Also, it
has been shown that stimulated resident glo-
merular macrophages have the faculty to release
cytokines such as IL-8, GM-CSF and TNF-a,
among others.39
It is well known that inorganic mercury
remains a major environmental toxin that alters
cell calcium homeostasis4 and mitochondrial
functions.
41 In concentrations commonly used in
experimental models the Hg
2+ acts as an iono-
phore as well as Cu+.42’3 In addition, the
administration of HgC12 causes the activation of
circulating lymphocytes, resulting in a polyclonal
B-cell activation
2 and also producing a direct
toxic effect on tubular renal cells. It is possible
that mercury also has the potential to induce the
activation of resident glomerular cells, thus initi-
ating the secretion of cytokines as TNF-a. This
local secretion of cytokines, in addition to stimu-
lating chemotaxis, can induce the recruitment of
circulating monocytes throughout the VtA-4/
VCAM-1 cell adhesion pathway. The mechanism
proposed could be supported based on the low
levels of TNF-0t in the supernatants of cultured
glomeruli and on the absence of renal tissue cell
infiltrates after mercury-injected rats were treated
with the anti-4 integrin.
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